iShares Morningstar Small-Cap Value ETF (ARCA: ISCV)

iShares Morningstar Small-Cap Value ETF (ARCA:ISCV), Trade Ideas

iShares Morningstar Small-Cap Value ETF

Jason Tsai, currently VP of IR and Finance at Silicon Motion, has been appointed Interim Chief Financial Officer of the Company effective as of April 25, 2024.&nbsp;

News

Management

SIMO

Silicon Motion Says Riyadh Lai Will Be Stepping Down As CFO, Effective April 25, 2024; Jason Tsai Named As Interim CFO

Craig-Hallum analyst Jeremy Hamblin initiates coverage on Red Robin Gourmet Burgers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRGB#NASDAQ">RRGB</a>) with a Buy rating and announces Price Target of $20.

Price Target

Initiation

Analyst Ratings

RRGB

Craig-Hallum Initiates Coverage On Red Robin Gourmet Burgers with Buy Rating, Announces Price Target of $20

WIIM

CARR

Carrier Global shares are trading higher, rebounding from earlier weakness following Q1 earnings.

Latest version enhances operational efficiency, regulatory reporting, and strategic decision-making with robust business insights

Tech

General

SPNS

Sapiens Unveils Enhanced Reinsurance and Analytics Solution Catering to Evolving Market Demands

California Water Servs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWT#NYSE">CWT</a>) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $0.36 by 236.11 percent. This is a 402.5 percent increase over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $270.75 million which beat the analyst consensus estimate of $183.85 million by 47.27 percent. This is a 106.52 percent increase over sales of $131.10 million the same period last year.

Earnings

Earnings Beats

California Water Servs Gr Q1 EPS $1.21 Beats $0.36 Estimate, Sales $270.75M Beat $183.85M Estimate

Commodities

Markets

LODE

Comstock Completed The Commissioning Stages Of Its Demonstration-scale Production Facility In Silver Springs, Nevada

Buybacks

Union Pacific Says Restarting Share Repurchases In Q2

Union Pacific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>) reported quarterly earnings of $2.69 per share which beat the analyst consensus estimate of $2.52 by 6.75 percent. The company reported quarterly sales of $6.00 billion which beat the analyst consensus estimate of $5.98 billion by 0.26 percent. This is a 0.92 percent decrease over sales of $6.06 billion the same period last year.

Union Pacific Q1 2024 Adj EPS $2.69 Beats $2.52 Estimate, Sales $6.00B Beat $5.98B Estimate

ULBI

Ultralife shares are trading higher after the company reported better-than-expected Q1 financial results.

2024 Full Year&nbsp;Guidance:
The Company reaffirms its FY 2024&nbsp;outlook&nbsp;for net sales of&nbsp;$3.42 billion&nbsp;to&nbsp;$3.58 billion, adjusted sales of&nbsp;$3.40 billion&nbsp;to&nbsp;$3.55 billion, net earnings and margin of&nbsp;$125 million&nbsp;to&nbsp;$160 million&nbsp;and&nbsp;3.7%&nbsp;to&nbsp;4.5%, respectively, adjusted EBITDA of&nbsp;$470 million&nbsp;to&nbsp;$510 million, and adjusted EBITDA margin of&nbsp;13.8%&nbsp;to&nbsp;14.4%. PHINIA expects to generate&nbsp;$160 million&nbsp;to&nbsp;$200 million&nbsp;in adjusted free cash flow. Adjusted tax rate is expected to be in the range of&nbsp;28%&nbsp;to&nbsp;32%.

Guidance

PHIN

PHINIA Reaffirms 2024 Outlook For Net Sales Of $3.42B-$3.58B, Adjusted Sales Of $3.40B-$3.55B Vs. $3.48B Consensus; Expects To Generate $160M-$200M In Adjusted Free Cash Flow

Summit Finl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMF#NASDAQ">SMMF</a>) reported quarterly earnings of $1.14 per share which beat the analyst consensus estimate of $1.07 by 6.54 percent. This is a 3.64 percent increase over earnings of $1.10 per share from the same period last year. The company reported quarterly sales of $45.001 million which beat the analyst consensus estimate of $44.674 million by 0.73 percent. This is a 16.66 percent increase over sales of $38.575 million the same period last year.

SMMF

Summit Finl Gr Q1 2024 GAAP EPS $1.14 Beats $1.07 Estimate, Sales $45.001M Beat $44.674M Estimate

Thursday,&nbsp;Virax Biolabs Group Limited&nbsp;(NASDAQ:&nbsp;VRAX) announced it is launching ‘ImmuneSelect' within the ViraxImmune T-Cell diagnostic platform for research-use-only (RUO) at the European Society of Clinical Microbiology and Infectious Diseases Global 2024 Congress.
"We are very pleased to launch ImmuneSelect, an important portfolio of immune profiling solutions within our ViraxImmune T-Cell diagnostic platform," commented Mr. James Foster, Chief Executive Officer of Virax Biolabs.
"The launch marks a significant milestone for Virax, as it brings us a step closer to commercializing ViraxImmune as a full in-Vitro Diagnostic product."&nbsp;
ImmuneSelect is the company's new portfolio of immune profiling solutions dedicated to investigating adaptive immunity.&nbsp;
ImmuneSelect&nbsp;is developed&nbsp;to evaluate T-Cell driven immunity and to aid in the understanding and early characterization of symptoms associated with post-viral syndromes, including&nbsp;Long&nbsp;COVID.
Products within the ImmuneSelect brand are for research and investigational use only and&nbsp;are not intended&nbsp;to&nbsp;be used&nbsp;as a diagnostics tool.&nbsp;
The ImmuneSelect portfolio includes peptide pools covering epitopes from pathogens linked to post-viral syndromes.&nbsp;
These include pools for SARS-CoV-2, SARS-CoV-2 MHC-1 (CD8), Lyme Disease, Cytomegalovirus, Respiratory Syncytial Virus, and Epstein-Barr Virus.&nbsp;
ImmuneSelect's Recombinant Antibodies target cytokines and biomarkers, and they are available in different versions unconjugated to&nbsp;be tested&nbsp;on a range of applications, including Flow Cytometry, ELISA, and ELISpot/Fluorospot.&nbsp;
Dr. Nigel McCracken, the Chief Operations Officer of Virax Biolabs, said, "We believe there is great potential to utilize T-Cell diagnostics to help detect underlying post-viral infections by initially measuring the body's adaptive immune resistance to infections and then monitoring the potential progression of an individual's T-Cell functions following chronic antigen stimulation."
Price Action:&nbsp;VRAX shares closed at $0.66 on Wednesday.

Biotech

Health Care

Market-Moving Exclusives

Exclusives

VRAX

EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes

The system has been using RevID&#39;s automated charge reconciliation for more than 2 years and has elected to add eValuator&#39;s code auditing technology for improved pre-bill revenue integrity.

Contracts

STRM

Streamline Health Expands Its Partnership With A 5 Facility, 700-Bed Oracle EHR Based Health System

PEGA

Pegasystems shares are trading lower following a Q1 revenue miss.

PCSA

Processa Pharmaceuticals shares are trading higher after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced an $8 price target.

Needham analyst Charles Shi reiterates Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) with a Buy and maintains $1030 price target.

Reiteration

LRCX

Needham Reiterates Buy on Lam Research, Maintains $1030 Price Target

These agreements enhance Plug&#39;s overall BEDP portfolio, bringing the company&#39;s total amount of global BEDP contracts to 4.5 gigawatts (GW).
Currently, 50MW of Plug&#39;s electrolyzers have been put into operations, and by the end of this year, Plug is expected be the largest provider of PEM technology operating in the world.

PLUG

Plug Power Signed Two Additional Contracts To Deliver Basic Engineering And Design Packages For Projects In Europe, US

HashiCorp shares are trading higher after IBM announced it will acquire the company for $35 per share.

CORRECTION: HashiCorp Ticker Is 'HCP'

CNX Resources shares are trading lower following a Q1 revenue miss.

Equity Market Expectations In 2024

Small-Cap Stocks May Be At Risk According To NFIB Data

Weekly Market Pulse: Artificial Intelligence?

Small Caps Are Due To Move Violently To The Upside

One Year After The Banking Crisis, How Are Regional Banks Faring?

Anatomy Of A Recession Update: Soft Landing Chances Rise

Growing Divergences In Small Vs. Large Caps

Markets, The Election, Trading Tips, And The 'Mag 7'-To-'Lag 7' Transition

Why Stocks Can Survive Bond Market Bumps

iShares Morningstar Small-Cap Value ETF declares quarterly distribution of $0.2555